The researcher requires small intestine cancer and normal RNA in order to use to study OLFM4 expression in small intestine cancer.
Ended Purchase Order Awarded
- Contract number
- HHSN268201700315PC
- Awardee
-
Proteogenex Inc. UEI F1BPAN698EL3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,530
Award facts
- Contract value 100% obligated
- $5,530.00 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Culver City, CA 90230, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN268201700315PC?
HHSN268201700315PC was awarded to Proteogenex Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on September 1, 2017.
How much is contract HHSN268201700315PC worth?
The government has obligated $5,530 on HHSN268201700315PC.
Was contract HHSN268201700315PC competed?
The extent of competition for HHSN268201700315PC was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award